Prevention, Diagnosis and Treatment of Infectious Diseases

Dear Colleagues,

The “Centre de recherche en Infectiologie” de l’Universite Laval ((CRI); Infectious Diseases Research Center at Laval University) is one of the largest centers dedicated to infectious diseases research in Canada. In 2024, the CRI will be commemorating its 50th anniversary. The CRI was established in 1974 by Dr. Michel G. Bergeron (ORCID: 0000-0002-0939-4435)—a recipient of prestigious honors, such as the Order of Canada, Order of Quebec, and Manning Award for life-time Innovation—who has published approximately 500 peer-reviewed publications.

To commemorate our research center’s 50th anniversary, the researchers of the CRI are contributing their research articles to this Special Issue of Infectious Disease Reports for spring 2024. This Special Issue will feature 9–10 peer-reviewed articles, each highlighting the discoveries and innovations made by CRI researchers, including the contribution of the founder, Dr. Bergeron, who contributed to important changes in the medical practice, such as the rapid (<1 h) molecular diagnosis of bacterial infections and resistance (the first-ever FDA-approved rapid diagnostic RT–PCR tests originated from the CRI team of Dr. Bergeron and now serve patients’ diagnostics in more than 60 countries by BD Diagnostics). The work of our CRI researchers covers all forefronts from better managing infections to addressing aspects of the prevention, diagnosis and treatment of bacterial, viral, fungal and parasitic infections.

This Special Issue of Infectious Disease Reports is designed to enable the rapid publication and dissemination of innovative research with the aim of advancing scientific and medical knowledge and highlighting future perspectives on the better management of microbes and infectious diseases to save lives and improve the quality of life of patients.

Prof. Dr. Marc Ouellette
Dr. Rabeea F. Omar
Dr. Sachiko Sato
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• managing infections (bacterial, viral and parasitic)
• prevention
• rapid molecular diagnosis
• treatment
• innovative solutions
• multidisciplinarity
• closing the loop and fulfilling patient’s unmet needs